Dogma Destroyed: "Neural Glue" Can Communicate!May 27, 2004For a long time glyacytes were merely regarded as a kind of glue which fills up the extra-cellular space in the brain and stabilises the nerve cells. However, researchers from the University of Bonn, together with their Swiss colleagues, have been able to prove convincingly for the first time that this "neural glue" is more communicative than was previously assumed: some kinds of glyacytes have small storage vesicles with messenger substances, what are known as neurotransmitters, which they can suddenly release into their surroundings when a chemical signal is given - a property which until recently was only ascribed to neurons. The dogma that information processing is exclusively the preserve of the neuron is thus no longer tenable. The findings are published in the June edition of Nature Neuroscience (vol. 7 No. 6, pp.613-620; http://www.nature.com/neuro/). In human beings glyacytes (glia in Greek means 'glue') are far more numerous than nerve cells, i.e. the neurons: almost 90% of all brain cells are one of the three types of glia (astrocytes, oligodendrocytes, microgliacells). Nevertheless, for a long time researchers into the brain only saw the glyacyte as a kind of "wet nurse" which looked after and fed the real stars of the show, the neurons. However, for some years now the signs have been increasing that the neglected neural glue should be accorded a more important role. The research team headed by Professor Christian Steinh'¤user and his Swiss colleague Professor Andrea Volterra have now been able to convincingly substantiate these suppositions by investigating brain specimens using the electron microscope and the methods of molecular biology: "We have found specific transport proteins in astrocytes which were previously only known to exist in nerve cells," Professor Steinh'¤user explains. In the neurons these "molecular conveyor belts" fill little internal cellular storage vesicles with the messenger substance glutamate. "We were able to demonstrate that there are glutamate vesicles like these in astrocytes, too - previously this assumption was vehemently opposed in some quarters. The transport proteins are located in the membrane of these vesicles." Using cell cultures the team proved that the vesicles really do work: "If the astrocytes are stimulated by activating a particular receptor, the vesicles merge with the membrane from within, thereby releasing their content - the glutamate - into the space between the astrocyte and its adjoining cells." The whole process takes place pretty quickly: within 0.2 seconds most of the storage vesicles have emptied - the transmission of chemical signals between two nerve cells in what is known as the "synaptic gap" takes place only a little faster. The messenger substance released also indirectly activated glutamate receptors in adjoining cells which the researchers had previously placed there as sensors to measure this activity. The astrocytes studied were from the hippocampus, a cerebral structure resembling a seahorse, which plays an important part in learning and memory processes. Hippocampus astrocytes have at their disposal an enormous number of finely networked projections; a single astrocyte from this region of the brain can, by releasing glutamate, theoretically influence up to 140,000 synapses which do not necessarily have to be situated in the immediate proximity. "The astroglial glutamate signal might therefore serve to modulate a large number of neurons," Professor Steinh'¤user explains. If this should be correct, the gliacytes would have unexpectedly graduated to being important players in the brain - with astrocytes as conductors which keep an orchestra of thousands of nerve cells playing in tune. Bonn, Universitaet |
|||||||||||||||||||||
| Related Neurons Current Events and Neurons News Articles Scripps research scientists find new link between insulin and core body temperature A team led by scientists at The Scripps Research Institute have discovered a direct link between insulin-a hormone long associated with metabolism and metabolic disorders such as diabetes-and core body temperature. New Down syndrome treatment suggested by Stanford/Packard study in mice At birth, children with Down syndrome aren't developmentally delayed. But as they age, these kids fall behind. Memory deficits inherent in Down syndrome hinder learning, making it hard for the brain to collect experiences needed for normal cognitive development. Cognitive dysfunction reversed in mouse model of Down syndrome A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down's syndrome. Pushing the brain to find new pathways Until recently, scientists believed that, following a stroke, a patient had about six months to regain any lost function. After that, patients would be forced to compensate for the lost function by focusing on their remaining abilities. Scientists decipher the formation of lasting memories Researchers at Karolinska Institutet have discovered a mechanism that controls the brain's ability to create lasting memories. In experiments on genetically manipulated mice, they were able to switch on and off the animals' ability to form lasting memories by adding a substance to their drinking water. Developmental delay could stem from nicotinic receptor deletion The loss of a gene through deletion of genetic material on chromosome 15 is associated with significant abnormalities in learning and behavior, said a consortium of researchers led by Baylor College of Medicine (www.bcm.edu) in a report that appears online today in the journal Nature Genetics. New TMS clinic offers noninvasive treatment for major depression Rush University Medical Center has opened the Transcranial Magnetic Stimulation (TMS) Clinic to offer patients suffering from major depression a safe, effective, non-drug treatment. Researchers explore new ways to prevent spinal cord damage using a vitamin B3 precursor Substances naturally produced by the human body may one day help prevent paralysis following a spinal cord injury, according to researchers at Weill Cornell Medical College. A recent $2.5 million grant from the New York State Spinal Cord Injury Research Board will fund their research investigating this possibility. Estrogen therapy likely must be given soon after menopause to provide stroke protection For estrogen replacement to provide stroke protection, it likely must be given soon after levels drop because of menopause or surgical removal of the ovaries, scientists report in the Journal of Neuroscience. Researchers identify drug candidate for treating spinal muscular atrophy A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants. More Neurons Current Events and Neurons News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||